Stay updated on EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.

Latest updates to the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page
- Check3 days agoChange DetectedDeleted the government funding operating status notice that was previously displayed on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe new screenshot shows minor UI adjustments and reorganization; core study details, eligibility criteria, and outcome measures appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check46 days agoChange DetectedPage now shows version v3.2.0 and a government-operating-status notice; old version v3.1.0 is removed.SummaryDifference5%

- Check54 days agoChange DetectedUpdated the page from version v3.0.2 to v3.1.0, reflecting a new software/document version.SummaryDifference0.1%

- Check68 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, and the Back to Top link was removed.SummaryDifference0.3%

- Check75 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.3%

Stay in the know with updates to EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.